...
首页> 外文期刊>Investigative ophthalmology & visual science >Selective Photoreceptor Degeneration by Intravitreal Injection of N-Methyl-N-Nitrosourea
【24h】

Selective Photoreceptor Degeneration by Intravitreal Injection of N-Methyl-N-Nitrosourea

机译:玻璃体内注射N-甲基-N-亚硝基脲选择性光感受器变性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose.: To characterize the effects of intravitreal injections of N-methyl-N-nitrosourea (MNU) in comparison to its systemic application as a measure of inducing unilateral photoreceptor degeneration. Methods.: Eight-week-old male C57BL/6J mice received either intraperitoneal injections (three animals) or intravitreal injections (24 animals) of MNU in different concentrations and were observed over a period of 2 weeks using full-field electroretinography (ERG), spectral-domain optical coherence tomography (SD-OCT), and immunohistochemistry. Results.: The intraperitoneal application of MNU showed moderate systemic toxic effects, indicated by a loss of body weight of 12% within the first 2 days. In both eyes the ERG became extinguished, and SD-OCT scans showed a thinning of the retina, predominantly in the outer nuclear layer (ONL). Immunohistochemistry demonstrated the selective loss of rods and cones. Mice that received intravitreal MNU injections displayed nearly no weight loss, and no degeneration of their general welfare was observed. After 2 weeks, ERG, SD-OCT, and immunohistochemistry revealed changes identical to those seen after systemic application in the injected eye, but not in the control eye. Conclusions.: The intraperitoneal application of MNU led to moderate systemic side effects in mice and to selective photoreceptor degeneration. Intravitreal injections of MNU also induced photoreceptor degeneration; however, no systemic side effects were observed. This tool may be helpful in larger species, where genetic models of receptor degenerations are not applicable but where the size of the eye is more suitable to study surgical or other approaches to treat blindness caused by receptor degeneration.
机译:目的:表征玻璃体内注射N-甲基-N-亚硝基脲(MNU)的效果及其与全身应用相比的诱导单侧光感受器变性的措施。方法:八周大的雄性C57BL / 6J小鼠接受了不同浓度的MNU腹膜内注射(三只动物)或玻璃体内注射(24只动物),并在2周内使用全场视网膜电图(ERG)进行了观察,光谱域光学相干断层扫描(SD-OCT)和免疫组织化学。结果:腹膜内应用MNU表现出中度全身毒性作用,这表明在头2天内体重减轻了12%。两只眼睛的ERG都消失了,SD-OCT扫描显示视网膜变薄,主要是在外核层(ONL)中。免疫组织化学证实了杆和视锥细胞的选择性损失。接受玻璃体内MNU注射的小鼠几乎没有体重减轻,也没有观察到其总体健康状况的恶化。 2周后,ERG,SD-OCT和免疫组织化学显示变化与注射眼中系统应用后看到的变化相同,但对照眼中则不同。结论:腹膜内应用MNU可导致小鼠中度全身性副作用,并导致选择性光感受器变性。玻璃体内注射MNU也会引起感光细胞变性。但是,未观察到全身性副作用。该工具在较大的物种中可能有用,这些物种的受体变性的遗传模型不适用,但眼睛的大小更适合研究手术或其他方法来治疗由受体变性引起的失明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号